StudyKIK

Headquartered in California, StudyKIK operates a global network connecting patients with clinical trials. The company offers a range of functions for clinical sites and research sponsors, including 1) patient recruitment tools, 2) site tools to manage patients over the trial period, 3) electronic consent functionality to guide patients through the enrollment process, and 4) study companion apps to help patients remain engaged during the trial.

In terms of compliance, the platform meets industry standards including HIPAA, 21 CFR Part 11, and ISO 27001.

As of June 2024, clients were offered several subscription plan options to choose from, starting from USD 2,200 for 30 days for the basic package and rising to USD 5,800 depending on the number of credits and posts required.

Key customers and partnerships

StudyKIK’s customer base as of June 2024 included companies like Genentech, Merck, Exact Sciences, and InGeneron. Additionally, it had supported 3.7 million+ patients, worked with over 3,600 research sites, and operated across 32+ countries.

Funding and financials

The company was acquired by Syneos Health in September 2021 for an undisclosed amount.